CN110121348A - 包含ed－71的固体分散体及油分散体的药物组合物 - Google Patents

包含ed－71的固体分散体及油分散体的药物组合物 Download PDF

Info

Publication number
CN110121348A
CN110121348A CN201780081610.0A CN201780081610A CN110121348A CN 110121348 A CN110121348 A CN 110121348A CN 201780081610 A CN201780081610 A CN 201780081610A CN 110121348 A CN110121348 A CN 110121348A
Authority
CN
China
Prior art keywords
soluble polymer
water soluble
cellulose
oil
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201780081610.0A
Other languages
English (en)
Chinese (zh)
Inventor
仓崎和贵
高野隆介
松冈庆宏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of CN110121348A publication Critical patent/CN110121348A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dispersion Chemistry (AREA)
CN201780081610.0A 2016-12-28 2017-12-28 包含ed－71的固体分散体及油分散体的药物组合物 Pending CN110121348A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2016-256379 2016-12-28
JP2016256379 2016-12-28
PCT/JP2017/047156 WO2018124260A1 (fr) 2016-12-28 2017-12-28 Composition médicinale comprenant une dispersion solide de ed-71 et une dispersion d'huile

Publications (1)

Publication Number Publication Date
CN110121348A true CN110121348A (zh) 2019-08-13

Family

ID=62709373

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201780081610.0A Pending CN110121348A (zh) 2016-12-28 2017-12-28 包含ed－71的固体分散体及油分散体的药物组合物

Country Status (5)

Country Link
JP (2) JP6905538B2 (fr)
KR (2) KR102366186B1 (fr)
CN (1) CN110121348A (fr)
TW (1) TWI784997B (fr)
WO (1) WO2018124260A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110946844A (zh) * 2019-12-11 2020-04-03 正大制药（青岛）有限公司 一种含有艾地骨化醇的复方控释制剂
CN110946837A (zh) * 2019-12-11 2020-04-03 正大制药（青岛）有限公司 用于治疗骨质疏松症的艾地骨化醇片及其制备方法
CN112368000A (zh) * 2018-06-27 2021-02-12 中外制药株式会社 含有在油脂中包含ed-71及其环氧体的油分分散体的药物组合物

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112770750A (zh) * 2018-07-30 2021-05-07 中外制药株式会社 乙内酰脲衍生物的固体分散体

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4729895A (en) * 1983-02-22 1988-03-08 Teijin Limited Composition for solid pharmaceutical preparations of active vitamins D.sub.3
JPH02240024A (ja) * 1989-03-13 1990-09-25 Ss Pharmaceut Co Ltd 活性型ビタミンｄ↓３類製剤用組成物
US5158944A (en) * 1989-03-01 1992-10-27 Teijin Limited Solid pharmaceutical preparations of active form of vitamin d3 of improved stability
EP1336602A1 (fr) * 2002-02-13 2003-08-20 Giovanni Scaramuzzino Prodrogues nitrées capable de libérer du monoxyde d'azote de manière controlée et sélective ainsi que leur utilisation pour la prévention et le traitement de maladies inflammatoires, ischémiques et proliferatives
CN1615139A (zh) * 2002-01-15 2005-05-11 Dsmip资产有限公司 25－羟基维生素d3组合物
WO2005074943A1 (fr) * 2004-02-06 2005-08-18 Chugai Seiyaku Kabushiki Kaisha Preparation de l’ed-71
WO2006075690A1 (fr) * 2005-01-14 2006-07-20 Ono Pharmaceutical Co., Ltd. Composition medicale stable
JP2007099760A (ja) * 2005-09-06 2007-04-19 Ono Pharmaceut Co Ltd 軟骨再生用医薬組成物
CN101534834A (zh) * 2006-11-06 2009-09-16 韩美药品株式会社 包含维生素d或其衍生物的固体分散体和双膦酸盐的用于预防或治疗骨质疏松症的复合制剂
CN101636152A (zh) * 2007-02-15 2010-01-27 株式会社Amorepacific 含有西洛他唑的控释制剂及其制备方法
CN102688249A (zh) * 2012-05-14 2012-09-26 北京阜康仁生物制药科技有限公司 一种含有锶盐的药用组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58206533A (ja) * 1982-05-27 1983-12-01 Teijin Ltd 活性型ビタミンｄ↓３誘導体組成物及びそれを活性成分とする薬剤
JPS6217A (ja) * 1985-02-14 1987-01-06 Chugai Pharmaceut Co Ltd 安定な活性型ビタミンｄ３類製剤
US9247765B2 (en) * 2004-01-14 2016-02-02 Omniactive Health Technologies Limited Stable beadlets of lipophilic nutrients
JP4934840B2 (ja) * 2008-08-20 2012-05-23 石川県 脂溶性ビタミンないし脂溶性ビタミン様物質の油脂−糖質粉末素材及びその製造方法
WO2015119183A1 (fr) * 2014-02-05 2015-08-13 協和発酵キリン株式会社 Médicament liquide contenant de la vitamine d3 active ou un dérivé de celle-ci

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4729895A (en) * 1983-02-22 1988-03-08 Teijin Limited Composition for solid pharmaceutical preparations of active vitamins D.sub.3
US5158944A (en) * 1989-03-01 1992-10-27 Teijin Limited Solid pharmaceutical preparations of active form of vitamin d3 of improved stability
JPH02240024A (ja) * 1989-03-13 1990-09-25 Ss Pharmaceut Co Ltd 活性型ビタミンｄ↓３類製剤用組成物
CN1615139A (zh) * 2002-01-15 2005-05-11 Dsmip资产有限公司 25－羟基维生素d3组合物
EP1336602A1 (fr) * 2002-02-13 2003-08-20 Giovanni Scaramuzzino Prodrogues nitrées capable de libérer du monoxyde d'azote de manière controlée et sélective ainsi que leur utilisation pour la prévention et le traitement de maladies inflammatoires, ischémiques et proliferatives
WO2005074943A1 (fr) * 2004-02-06 2005-08-18 Chugai Seiyaku Kabushiki Kaisha Preparation de l’ed-71
CN101721708A (zh) * 2004-02-06 2010-06-09 中外制药株式会社 Ed-71制剂
WO2006075690A1 (fr) * 2005-01-14 2006-07-20 Ono Pharmaceutical Co., Ltd. Composition medicale stable
JP2007099760A (ja) * 2005-09-06 2007-04-19 Ono Pharmaceut Co Ltd 軟骨再生用医薬組成物
CN101534834A (zh) * 2006-11-06 2009-09-16 韩美药品株式会社 包含维生素d或其衍生物的固体分散体和双膦酸盐的用于预防或治疗骨质疏松症的复合制剂
CN101636152A (zh) * 2007-02-15 2010-01-27 株式会社Amorepacific 含有西洛他唑的控释制剂及其制备方法
CN102688249A (zh) * 2012-05-14 2012-09-26 北京阜康仁生物制药科技有限公司 一种含有锶盐的药用组合物

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
HAGINO H ET AL: "Eldecalcitol: newly developed active vitamin D-3 analog for the treatment of osteoporosis", 《EXPERT OPIN. PHARMACOTHER.》 *
张光杰 等: "《药用辅料应用技术》", 31 December 1991, 中国医药科技出版社 *
方亮: "《药剂学》", 31 March 2016, 中国医药科技出版社 *
杨艳兰 等: "2β-(3羟丙氧)-骨化三醇对OS-732人成骨样细胞增殖与分化的影响", 《中华老年医学杂志》 *
甄汉深 等: "《药物分析学》", 31 October 2011, 中国中医药出版社 *
郝敬东 等: "肢体延长的大鼠模型", 《中华小儿外科杂志》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112368000A (zh) * 2018-06-27 2021-02-12 中外制药株式会社 含有在油脂中包含ed-71及其环氧体的油分分散体的药物组合物
CN110946844A (zh) * 2019-12-11 2020-04-03 正大制药（青岛）有限公司 一种含有艾地骨化醇的复方控释制剂
CN110946837A (zh) * 2019-12-11 2020-04-03 正大制药（青岛）有限公司 用于治疗骨质疏松症的艾地骨化醇片及其制备方法

Also Published As

Publication number Publication date
TWI784997B (zh) 2022-12-01
JP2021155437A (ja) 2021-10-07
KR102583517B1 (ko) 2023-09-26
KR102366186B1 (ko) 2022-02-21
JP6905538B2 (ja) 2021-07-21
JP7196239B2 (ja) 2022-12-26
WO2018124260A1 (fr) 2018-07-05
KR20220025177A (ko) 2022-03-03
JPWO2018124260A1 (ja) 2019-10-31
TW201834661A (zh) 2018-10-01
KR20190101981A (ko) 2019-09-02

Similar Documents

Publication Publication Date Title
CN110121348A (zh) 包含ed－71的固体分散体及油分散体的药物组合物
CN102451179B (zh) 一种含番茄红素,白藜芦醇或褪黑素的肠溶固体制剂及其制备方法
CN105828806A (zh) 制剂
NO333301B1 (no) Farmasoytisk sammensetning som inneholder fenofibrat og fremgangsmate til fremstilling derav
CN1741748A (zh) 粉末状植物甾醇配方
CN105007898A (zh) 难溶性药物的过饱和的稳定纳米颗粒
KR20090092288A (ko) 뉴로키닌 길항제를 포함하는 제약 제형
CA3110020A1 (fr) Formes posologiques pediatriques de vitamine d, procedes de fabrication et d'utilisation de celles-ci
Xue et al. A combined utilization of Plasdone-S630 and HPMCAS-HF in ziprasidone hydrochloride solid dispersion by hot-melt extrusion to enhance the oral bioavailability and no food effect
JP6053425B2 (ja) ジベンゾ［ｂ，ｅ］オキセピン誘導体を含有する固形製剤
JP2000191516A (ja) 経口固形組成物
CN104619175A (zh) 延长释放左乙拉西坦和制备方法
JP4060027B2 (ja) ビタミンｋ含有組成物
EP2050436A1 (fr) Composition pharmaceutique qui comporte de la dutastéride
JP2015078183A (ja) 固体分子分散物
JP3833314B2 (ja) 発泡性組成物およびその製造方法
CN105435239B (zh) 美索舒利薄膜衣片及其制备方法
WO2023168316A1 (fr) Formulations de cannabinoïdes sous forme de poudre sèche à enrobage entérique
Wang et al. Preparation and evaluation of tamsulosin hydrochloride sustained-release pellets modified by two-layered membrane techniques
JP3895757B1 (ja) 粉末状組成物
JP7406581B2 (ja) 油脂中にｅｄ－７１およびそのエポキシ体を含む油分分散体を含む医薬組成物
CN113893222B (zh) 一种药物组合物及其制备方法和用途
Aung et al. Supersaturable Solid Self-microemulsifying Delivery Systems of Astaxanthin via Spray Drying: Effects of Polymers and Solid Carriers
JPH02300117A (ja) 固形医薬製剤の製造方法
JPH11209306A (ja) 高薬物含有率徐放製剤の製法

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40007075

Country of ref document: HK